Laura Rogers

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 15, 2026
Sleeping Beauty mutagenesis identifies BACH2 and other regulators of CD8+ T-cell exhaustion, persistence in vivo, and CAR-T cell function under tumor-associated chronic antigen stimulation.

|Jul 07, 2026
Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ-mediated inflammatory death program.

|Apr 08, 2026
NetCIS: a network-based common insertion site pipeline for case-control Sleeping Beauty screens.

Mathew J Fischbach, Daniel E Reiter, Wen Wang

|Dec 09, 2025
Functional genomics for improving adoptive T-cell transfer therapies.

Joseph G Skeate, Chang-Jung Lee, Carli Stewart

|Aug 16, 2024
TBK1 and IKKε protect target cells from IFNγ-mediated T cell killing via an inflammatory apoptotic mechanism.

Nicholas D Sun, Allison R Carr, Erica N Krogman

|May 02, 2023
Dual TCR-Expressing T Cells in Cancer: How Single-Cell Technologies Enable New Investigation.

Elizabeth M Muhowski, Laura M Rogers

Pageof 2

Frequent Collaborators

2 joint publications

Nicholas D Sun

2 joint publications

Allison R Carr

2 joint publications

Yogesh Chawla

2 joint publications

Jun Zhong